openPR Logo
Press release

Polycystic Ovarian Syndrome Treatment Market 2019 Extensive Growth in Business Future Scenarios and Brief Analysis of Top Key Players

03-11-2020 02:26 PM CET | Health & Medicine

Press release from: Allied Market Research

Polycystic Ovarian Syndrome Treatment Market

Polycystic Ovarian Syndrome Treatment Market

The global polycystic ovarian syndrome treatment market size was valued at $2,902 million in 2018, and is projected to reach $4,184 million by 2026, growing at a CAGR of 4.7% from 2019 to 2026.

Polycystic ovarian syndrome or PCOS is a hormonal disorder that occurs in women during their childbearing age and is characterized by formation of cyst on ovaries. PCOS often leads to hirsutism, obesity, infertility, and diabetes, thus, needs effective management. Presently, there is no cure for PCOS, but different types of medications, such as insulin sensitizing agent, oral contraceptive, antiandrogens, and anti-obesity drugs are used to manage PCOS.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/6314

The polycystic ovarian syndrome treatment market is expected to experience significant growth during the forecast period owing to rise in demand for PCOS treatment medication across different regions and increase in popularity combination therapy majorly drives the market growth. Increase in prevalence of PCOS is expected to further boost the polycystic ovarian syndrome treatment market growth during the forecast period. In addition, significant unmet need for PCOS treatment, increase in R&D activities to develop PCOS therapeutics, and growing demand forof PCOS therapeutics in developing countries further creates opportunities for the PCOS treatment market. However, lack of approved drugs and adverse effects associated with off label drugs are anticipated to hamper the market growth.

On the basis of drug class, the market is categorized into insulin sensitizing agent, oral contraceptive, antiandrogens, anti-obesity drugs, and others. Presently, the insulin sensitizing agent segment is the major revenue contributing segment and is estimated to show a significant market growth during the forecast period, owing to higher adoption of insulin sensitizing agents as first line treatment in the management of PCOS.

According to distribution channel, the polycystic ovarian syndrome treatment market is classified into hospital pharmacies, drug stores & retail pharmacies, and online providers. The online providers segment is anticipated to depict significant growth during the forecast period, attributed to the rise in preference for online purchasing of drugs over traditional methods, increase in awareness of online pharmacy, and rise in number of internet users.

Get a purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/6314

North America accounted for approximately one-half of the global polycystic ovarian syndrome treatment market share in 2018 and is expected to remain dominant throughout the forecast period. This was attributed to the rise in adoption of polycystic ovarian syndrome treatment medications, well developed healthcare infrastructure, large number of target population with higher health awareness, wide availability of advanced polycystic ovarian syndrome treatment therapeutics, and supportive reimbursement policies in the healthcare system. In addition, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to growing prevalence of PCOS, and increase in the adoption of polycystic ovarian syndrome treatment medication for the same.

The Major key players Are:

o Allergan plc.
o AstraZeneca plc.
o Bayer AG
o Bristol-Myers Squibb Company
o Johnson and Johnson
o Mylan N.V.
o Novartis AG
o Pfizer Inc.
o SANOFI
o Teva Pharmaceutical Industries.

Access Full Report @ https://www.alliedmarketresearch.com/polycystic-ovarian-syndrome-treatment-market-A05949

Key Findings of the Study:

o Based on drug class, the insulin sensitizing agent segment held more than one half of share in the global market in 2018.
o Based on end user, the online providers segment exhibits fastest growth and is expected to grow at a CAGR of 6.3% from 2019 to 2026.
o Based on end user, the drug stores & retail pharmacies segment held the largest market share in 2018 and is expected to remain dominant throughout the forecast period.
o Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.3% during the forecast period.

Similar Reports:

Bioreactors Market: https://www.alliedmarketresearch.com/bioreactors-market

Global Disposable Urinary Drainage Bag Market: https://www.alliedmarketresearch.com/disposable-urinary-drainage-bag-market

Bone & Mineral Testing Market: https://www.alliedmarketresearch.com/bone-and-mineral-testing-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client's insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Polycystic Ovarian Syndrome Treatment Market 2019 Extensive Growth in Business Future Scenarios and Brief Analysis of Top Key Players here

News-ID: 1962444 • Views:

More Releases from Allied Market Research

Substation Automation Market Growing Demand, Future Trends, Competitive Regions | ABB Ltd, Schneider Electric
Substation Automation Market Growing Demand, Future Trends, Competitive Regions …
Allied Market Research published an exclusive report, titled, "Substation Automation Market by Component (Reclose Controller, Programmable Logical Controller, Capacitor Bank Controller, Digital Transducer/Smart Meter, Load Tap Controller, and Communication Channel), Module (SCADA, IED, and Communication Network Technology), and Communication Channel (Ethernet, Power Line Communication, Copper Wire Communication, and Optical Fiber Communication) - Global Opportunity Analysis and Industry Forecast, 2014-2022". Download Research Report Sample & TOC : https://www.alliedmarketresearch.com/request-sample/1922 The substation automation market report
Infrared Detector Market Generate Massive Revenue in Upcoming Future 2030 | FLIR Systems Inc., Murata Manufacturing
Infrared Detector Market Generate Massive Revenue in Upcoming Future 2030 | FLIR …
Allied Market Research published an exclusive report, titled, "Infrared Detector Market by Type (Thermal Detector and Photo detector), Spectral Range (Short-Wave IR, Medium-Wave IR, and Long-Wave IR), Application (Aerospace & Defense, Industrial, Medical, Automotive, Security, and Consumer Electronics) - Global Opportunity Analysis and Industry Forecasts, 2014-2022". Download Research Report Sample & TOC : https://www.alliedmarketresearch.com/request-sample/1771 The infrared detector market report offers a detailed analysis of prime factors that impact the market growth such
Paint Roller Market Exhibit a Remarkable CAGR of 5.5% and is expected to reach $3.18 billion by 2027
Paint Roller Market Exhibit a Remarkable CAGR of 5.5% and is expected to reach $ …
Paint Roller Market by Fabric (Synthetic and Blended), Frame Size (Shorter, Medium, and Large), and End User (Residential, Commercial, and Industrial): Global Opportunity Analysis and Industry Forecast, 2020-2027". As per the report, the global paint roller industry was pegged at $2.38 billion in 2019, and is projected to reach $3.18 billion by 2027, growing at a CAGR of 5.5% from 2020 to 2027. Drivers, restraints, and opportunities Increase in demand for various
Green Mining Market to Grow at a CAGR of 9.5% and Expected to Reach $27.9 billion by 2032
Green Mining Market to Grow at a CAGR of 9.5% and Expected to Reach $27.9 billio …
The Global Green Mining Market size was valued at $11.4 billion in 2023, and is projected to reach $27.9 billion by 2032, growing at a CAGR of 9.5% from 2023 to 2032. The High-Pressure Grinding Roller Market report defines and outlines the products, applications, and specifications to the reader. The study lists the leading companies operating in the Market and highlights the key change processes that companies have adopted to

All 5 Releases


More Releases for PCOS

Global Polycystic Ovary Syndrome (PCOS) Market Research and Forecast 2018-2023
Global polycystic ovary syndrome market size, share, market trends, research and analysis report by diagnosis (ultrasound, pelvic exam, blood test) by treatment (ovarian wedge resection, laparoscopic ovarian drilling, acupuncture) forecast 2018-2023 According to the OMR analysis, the global polycystic ovarian syndrome is growing at a significant rate during 2018-2023. The global polycystic ovarian syndrome has been growing significantly due to initiatives taken by the government authorities regarding early diagnosis of the
Polycystic Ovary Syndrome (PCOS) Drugs Market 2018: BIOCAD, Merck KGaA, AstraZen …
Qyresearchreports include new market research report “2018-2025 Polycystic Ovary Syndrome (PCOS) Drugs Report on Global and United States Market, Status and Forecast, by Players, Types and Applications” to its huge collection of research reports. The global Polycystic Ovary Syndrome (PCOS) Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017
Polycystic Ovary Syndrome (PCOS) Drugs Market 2018: BIOCAD, Merck KGaA, AstraZen …
Qyresearchreports include new market research report “2018-2025 Polycystic Ovary Syndrome (PCOS) Drugs Report on Global and United States Market, Status and Forecast, by Players, Types and Applications” to its huge collection of research reports. The global Polycystic Ovary Syndrome (PCOS) Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017
Polycystic Ovarian Syndrome (PCOS) Treatment Market Healthcare, Clinical Reviews …
Qyresearchreports include new market research report Global Polycystic Ovarian Syndrome (PCOS) Treatment Market Size, Status and Forecast 2022 to its huge collection of research reports. The growth trajectory of the global Polycystic Ovarian Syndrome (PCOS) Treatment market is shaped by a wide range of strategic factors and demand dynamics, a critical assessment of which is given in this report. The market is also influenced by changes in governmental regulations in key
Discover the Growth of the Polycystic Ovarian Syndrome (PCOS) Therapeutics Marke …
Polycystic ovarian syndrome (PCOS) is an endocrine disorder observed in females during their reproductive age, due to which they may suffer from infertility problems. PCOS is characterized by a range of symptoms such as acne, menstrual irregularities, hirsutism, obesity, insulin resistance, anovulation and infertility. PCOS therapeutics include a wide a range of medications that are available in the worldwide. The global market for PCOS therapeutics can be segmented into six
By 2024, PCOS Drugs Market to Rise at 4.6% CAGR
The global polycystic ovary syndrome drugs market is expected to register a CAGR of 4.6% during the forecast period 2016–2024 and is expected to expand 1.5x in terms of revenue by 2024. The report analyzes the global PCOS drugs market performance and provides information on key drivers and trends likely to impact the market during the forecast period. Growth of the global polycystic ovary syndrome drugs market is mainly driven by